DE NOVO MYELODYSPLASTIC SYNDROME

Clinical trials for DE NOVO MYELODYSPLASTIC SYNDROME explained in plain language.

Never miss a new study

Get alerted when new DE NOVO MYELODYSPLASTIC SYNDROME trials appear

Sign up with your email to follow new studies for DE NOVO MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

Major trial tests if adding a hormone boosts blood cell Drug's power

Disease control Ongoing

This large, late-stage trial is comparing two treatment approaches for patients with a bone marrow disorder (MDS) and severe anemia. It tests whether a drug called lenalidomide works better alone or when combined with a hormone (epoetin alfa) that helps the body make red blood ce…

Matched conditions: DE NOVO MYELODYSPLASTIC SYNDROME

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 16, 2026 15:23 UTC

DE NOVO MYELODYSPLASTIC SYNDROME

Get alerted when new DE NOVO MYELODYSPLASTIC SYNDROME trials appear

Major trial tests if adding a hormone boosts blood cell Drug's power